COLOR DOPPLER ULTRASOUND ANALYSIS OF OCULAR CIRCULATION AFTER TOPICAL CALCIUM-CHANNEL BLOCKER

被引:61
|
作者
NETLAND, PA [1 ]
GROSSKREUTZ, CL [1 ]
FEKE, GT [1 ]
HART, LJ [1 ]
机构
[1] HARVARD UNIV,SCH MED,SCHEPENS EYE RES INST,BOSTON,MA
关键词
D O I
10.1016/S0002-9394(14)72772-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To investigate the effect of topical administration of the calcium channel blocker verapamil on intraocular pressure and retrobulbar hemodynamics. METHODS: Tn this randomized, prospective, double-masked study, we examined the effects of single-dose topical administration of verapamil in ten normal human volunteers by using color Doppler ultrasound imaging to measure hemodynamic parameters. Limitations of this study in elude single-dose application of verapamil and relatively small sample size. RESULTS: No systemic effect on heart rate or blood pressure was detected after administration of topical verapamil. The intraocular pressure significantly decreased compared with baseline two hours after topical 0.125% and 0.25% verapamil (P = .015 and .040, respectively). Pourcelot's ratio, an index of vascular resistance, measured in the central retinal artery was significantly reduced after topical application of 0.125% verapamil (P = .008). The change in Pourcelot's ratio primarily resulted from an increased end diastolic velocity in the central retinal artery. No significant difference es compared with baseline values were detected in the color Doppler ultrasound measurements of the posterior ciliary arteries and the central retinal vein two hours after topically administered verapamil. CONCLUSIONS: Topical administration of verapamil decreases intraocular pressure and alters ocular hemodynamics, reducing the vascular resistance index in the central retinal artery.
引用
收藏
页码:694 / 700
页数:7
相关论文
共 50 条
  • [21] Color Doppler imaging of ocular blood flow after topical ketanserin
    Cellini, M
    Caramazza, R
    OPHTHALMOLOGICA, 1999, 213 (05) : 286 - 289
  • [22] THE CALCIUM-CHANNEL BLOCKER SCARE - LESSONS FOR THE FUTURE
    LENFANT, C
    CIRCULATION, 1995, 91 (12) : 2855 - 2856
  • [23] METABOLIC EFFECTS OF CALCIUM-CHANNEL BLOCKER THERAPY
    COLLINS, WCJ
    CULLEN, MJ
    FEELY, J
    IRISH JOURNAL OF MEDICAL SCIENCE, 1986, 155 (09) : 332 - 332
  • [24] THE EFFECT OF A CALCIUM-CHANNEL BLOCKER ON BONE MINERALIZATION
    CHARNOV, JH
    KAHN, EK
    CAIOZZO, VJ
    CLINICAL RESEARCH, 1988, 36 (01): : A150 - A150
  • [25] THE SYNTHESIS OF A CONFORMATIONALLY RIGID CALCIUM-CHANNEL BLOCKER
    BARRISH, JC
    SPERGEL, SH
    MORELAND, S
    HEDBERG, SA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (01) : 95 - 98
  • [26] CALCIUM-CHANNEL BLOCKER FOR TREATMENT OF MALIGNANT HYPERTHERMIA
    IWATSUKI, N
    KOGA, Y
    AMAHA, K
    ANESTHESIA AND ANALGESIA, 1983, 62 (09): : 861 - 862
  • [27] THE BINDING OF THE CALCIUM-CHANNEL BLOCKER, BEPRIDIL, TO CALMODULIN
    ITOH, H
    TANAKA, T
    MITANI, Y
    HIDAKA, H
    BIOCHEMICAL PHARMACOLOGY, 1986, 35 (02) : 217 - 220
  • [28] AMIODARONE - A USE DEPENDENT CALCIUM-CHANNEL BLOCKER
    TALAJIC, M
    DEROODE, MR
    QUANTZ, MA
    NATTEL, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : A50 - A50
  • [29] NISOLDIPINE - A NEW DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKER
    MITCHELL, J
    FRISHMAN, W
    HEIMAN, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (01): : 46 - 52
  • [30] PROLONGED CALCIUM-CHANNEL BLOCKER THERAPY OF HYPERTENSION
    WEBER, MA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 : S16 - S21